microRNA-23a in human cancer: its roles, mechanisms and therapeutic relevance

N Wang, HY Tan, YG Feng, C Zhang, F Chen, Y Feng - Cancers, 2018 - mdpi.com
microRNA-23a (miR-23a) is one of the most extensively studied miRNAs in different types of
human cancer, and plays various roles in the initiation, progression, and treatment of tumors …

The key role of microRNAs in initiation and progression of hepatocellular carcinoma

S Khan, DY Zhang, JY Zhang, MK Hayat, J Ren… - Frontiers in …, 2022 - frontiersin.org
Hepatocellular carcinoma (HCC) is the main type of primary liver malignancy and the fourth
leading cause of cancer-related death worldwide. MicroRNAs (miRNAs), a type of non …

Cluster miRNAs and cancer: Diagnostic, prognostic and therapeutic opportunities

SP Kabekkodu, V Shukla, VK Varghese… - Wiley …, 2020 - Wiley Online Library
MiRNAs are class of noncoding RNA important for gene expression regulation in many
plants, animals and viruses. MiRNA clusters contain a set of two or more miRNA encoding …

A feedback loop between miR-30a/c-5p and DNMT1 mediates cisplatin resistance in ovarian cancer cells

X Han, S Zhen, Z Ye, J Lu, L Wang, P Li, J Li… - Cellular Physiology and …, 2017 - karger.com
Abstract Background: Many microRNAs (miRs) are dysregulated in cancers, and aberrant
miR expression patterns have been suggested to correlate with chemo-resistance of cancer …

Long non-coding RNA TUSC7 acts a molecular sponge for miR-10a and suppresses EMT in hepatocellular carcinoma

Y Wang, Z Liu, B Yao, C Dou, M Xu, Y Xue, L Ding… - Tumor Biology, 2016 - Springer
Despite advances in the roles of long non-coding RNA (lncRNA) tumor suppressor
candidate 7 (TUSC7) in cancer biology, which has been identified as a tumor suppressor by …

Intermittent hypoxia alleviates increased VEGF and pro-angiogenic potential in liver cancer cells

G Dong, XH Lin, HH Liu, DM Gao, JF Cui… - Oncology …, 2019 - spandidos-publications.com
Vascular endothelial growth factor (VEGF) is an important angiogenic factor. The VEGF
rebound induced by hypoxia following transarterial embolization/chemoembolization for …

SIRT1 in the development and treatment of hepatocellular carcinoma

M Farcas, AA Gavrea, D Gulei, C Ionescu… - Frontiers in …, 2019 - frontiersin.org
Hepatocellular carcinoma (HCC) is one of the most common causes of cancer-related death
worldwide. Current treatment options for inoperable HCCs have decreased therapeutic …

MiR-30e inhibits tumor growth and chemoresistance via targeting IRS1 in Breast Cancer

M Liu, Z Li, X Han, J Shi, D Tu, W Song, J Zhang… - Scientific reports, 2017 - nature.com
Abstract MicroRNA-30e (miR-30e) is downregulated in various tumor types. However, its
mechanism in inhibiting tumor growth of breast cancer remains to be elucidated. In this …

Circulating miR-26a, miR-106b, miR-107 and miR-133b stratify hepatocellular carcinoma patients according to their response to transarterial chemoembolization

HEA Ali, AA Emam, AA Zeeneldin, R Srour… - Clinical …, 2019 - Elsevier
Background A number of hepatocellular carcinoma (HCC) patients have developed
resistance against transcatheter arterial chemoembolization (TACE) treatment. In this study …

[HTML][HTML] Comparison of microRNA profiles between benign and malignant salivary gland tumors in tissue, blood and saliva samples: a prospective, case-control study …

O Cinpolat, ZN Unal, O Ismi, A Gorur… - Brazilian Journal of …, 2017 - SciELO Brasil
Abstract Introduction: Salivary gland tumors (SGTs) are rare head and neck malignancies
consisting of a spectrum of tumors with different biological behaviors. Objective: In this study …